VIRAL TRANSPORTATION IN COVID-19 PANDEMIC: INACTIVATED VIRUS TRANSPORTATION SHOULD BE IMPLEMENTED FOR SAFE TRANSPORTATION AND HANDLING AT DIAGNOSTICS LABORATORIES.
Rajan Dewar, David Baunoch, Kirk Wojno, Vinita Parkash, Roya Khosravi-Far
Author Information
- Rajan Dewar: Department of Pathology, University of Michigan, Ann Arbor Michigan (Dr. Dewar); Pathnostics Inc, Irvine, California (Dr. Baunoch); Department of Pathology, Yale School of Medicine, New Haven, Connecticut (Dr. Wojno); Oncocell dx, Royal Oak, Michigan (Dr. Parkash); Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA (Dr. Khosravi-Far); Accurome Health, Inc. Boston, MA (Dr. Khosravi-Far).
- David Baunoch: Department of Pathology, University of Michigan, Ann Arbor Michigan (Dr. Dewar); Pathnostics Inc, Irvine, California (Dr. Baunoch); Department of Pathology, Yale School of Medicine, New Haven, Connecticut (Dr. Wojno); Oncocell dx, Royal Oak, Michigan (Dr. Parkash); Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA (Dr. Khosravi-Far); Accurome Health, Inc. Boston, MA (Dr. Khosravi-Far).
- Kirk Wojno: Department of Pathology, University of Michigan, Ann Arbor Michigan (Dr. Dewar); Pathnostics Inc, Irvine, California (Dr. Baunoch); Department of Pathology, Yale School of Medicine, New Haven, Connecticut (Dr. Wojno); Oncocell dx, Royal Oak, Michigan (Dr. Parkash); Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA (Dr. Khosravi-Far); Accurome Health, Inc. Boston, MA (Dr. Khosravi-Far).
- Vinita Parkash: Department of Pathology, University of Michigan, Ann Arbor Michigan (Dr. Dewar); Pathnostics Inc, Irvine, California (Dr. Baunoch); Department of Pathology, Yale School of Medicine, New Haven, Connecticut (Dr. Wojno); Oncocell dx, Royal Oak, Michigan (Dr. Parkash); Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA (Dr. Khosravi-Far); Accurome Health, Inc. Boston, MA (Dr. Khosravi-Far).
- Roya Khosravi-Far: Department of Pathology, University of Michigan, Ann Arbor Michigan (Dr. Dewar); Pathnostics Inc, Irvine, California (Dr. Baunoch); Department of Pathology, Yale School of Medicine, New Haven, Connecticut (Dr. Wojno); Oncocell dx, Royal Oak, Michigan (Dr. Parkash); Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA (Dr. Khosravi-Far); Accurome Health, Inc. Boston, MA (Dr. Khosravi-Far).
No abstract text available.